Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system

Nirashaa Bound(Walter and Eliza Hall Institute of Medical Research), Clare L. Scott(Royal Women's Hospital)
Frontiers in Genetics
September 9, 2022
Cited by 23


Related Papers